http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9110428-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9f1fc4fbb9a52f3b5c5eac916cd8039
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 1991-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79885c6d8c471b6c8ad7b747620fe16a
publicationDate 1991-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9110428-A1
titleOfInvention Drugs and use thereof
abstract The present invention relates to atenolol-based drugs intended for beta receptor blockade and for treatment of hypertension, and also a method for reducing, with the aid of these drugs, the toxic effect upon drug treatment in order to achieve the desired level of beta receptor blockade or the desired reduction in blood pressure upon drug treatment for hypertension.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9498437-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004075856-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7579331-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004075856-A2
priorityDate 1990-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4085136-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0193227-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4182911-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID56781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227077143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180559
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175540
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID56781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129349967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21438926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396376

Total number of triples: 49.